FIGURE
Fig. 6
- ID
- ZDB-FIG-130907-31
- Publication
- McCarthy et al., 2013 - Pdgfra protects against ethanol-induced craniofacial defects in a zebrafish model of FASD
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 6
Wortmannin and rapamycin phenocopy ethanol-treated pdgfra mutants. (A-L) 5 dpf zebrafish neurocrania embryos were treated at 10-24 hpf with (A-C) DMSO, (D-F) 1.0% ethanol, (G-I) 1.5 μM wortmannin or (J-L) 3 μM rapamycin. Asterisks indicate ethmoid-plate defects (ep); arrowheads indicate trabeculae defects (tr). (M) Graph of percentage defects found in all three genotypes, across treatments. Unaffected, wild-type phenotype; ep, ethmoid-plate defects (arrow and asterisk in K); tr, trabeculae defects (arrowheads in H). |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
| Fish: | |
|---|---|
| Conditions: | |
| Observed In: | |
| Stage: | Day 5 |
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Development